Taking an HPV vaccine research-tested intervention to scale in a clinical setting

Suellen Hopfer, Anne E. Ray, Michael L. Hecht, Michelle Miller-Day, Rhonda Belue, Gregory Zimet, W. Douglas Evans, Francis X. McKee

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Research tested interventions are seldom ready for wide spread use. Successful intervention adaptation to clinical settings demands an iterative process with target audience feedback. We describe the adaptation process of implementing an NCI research tested HPV vaccine intervention, Women's Stories, to a community clinic context (Planned Parenthood). Five phases are described for the adaptation of content and the development of a health kiosk intervention delivery system: (a) informant interviews with the target audience of young adult, predominantly African-American women, (b) translating HPV vaccine decision narratives into prevention messages, (c) health kiosk interface design, (d) conducting a usability study of the health kiosk intervention product, and (e) conducting a waiting room observational study. Lessons learned and challenges in adapting prevention interventions to clinical settings are discussed.

Original languageEnglish
Pages (from-to)745-752
Number of pages8
JournalTranslational Behavioral Medicine
Issue number5
StatePublished - Sep 8 2018

Bibliographical note

Funding Information:
Acknowledgements: This research was supported by grant R43 CA192437-01A1 from the National Cancer Institute. The research presented in this paper is that of the authors and does not reflect the official policy of the National Institutes of Health nor the views of Planned Parenthood Federation of America, Inc. We thank Planned Parenthood for their collaboration and dedication to improving women’s health.

Funding Information:
Conflicts of Interest: S.H. is affiliated with REAL Prevention, LLC and will profit from marketing the intervention. A.E.R. has no financial disclosures. M.H. is owner of REAL Prevention, LLC that will profit from marketing the intervention. M.M. is owner of REAL Prevention, LLC that will profit from marketing the intervention. R.B. has no financial disclosures. G.Z. has been an investigator on an investigator-initiated HPV research funded by Merck and Roche, received travel support from Merck to present research findings at a scientific meeting, and an honorarium from Sanofi Pasteur for participation in an adolescent immunization working group. W.D.E. has no financial disclosures. F.X.M., owner of St. Andrews Development has no financial disclosure but does have an arrangement with REAL Prevention to profit from marketing the HPV intervention described in this manuscript.

Publisher Copyright:
© Society of Behavioral Medicine 2018.


  • Adapting an Intervention
  • African American
  • Decision Narratives
  • Dissemination
  • HPV vaccine
  • Health Equity
  • Implementation

ASJC Scopus subject areas

  • Applied Psychology
  • Behavioral Neuroscience


Dive into the research topics of 'Taking an HPV vaccine research-tested intervention to scale in a clinical setting'. Together they form a unique fingerprint.

Cite this